Member of the Supervisory Board @ Immunic Ag (January 2017 - May 2019)
Biotech Manager and Entrepreneur @ Consultant and Board Member (January 2019 - Present)
Chief Financial Officer @ (January 2017 - January 2018)
Member of the Board @ (May 2017 - Present)
Chief Executive Officer and Chief Financial Officer @ (April 2011 - June 2016)
Chief Financial Officer @ (November 2008 - March 2011)
Chief Financial Officer @ Elbion (January 2005 - January 2008)
Partner @ DVC Deutsche Venture Capital (January 2003 - January 2005)
Director Venture Capital Activities @ (January 1998 - January 2002)
Research Scientist @ (January 1995 - January 1998)
Postdoc and Feodor Lynen Fellow of the Alexander Von Humboldt Foundation @ (January 1994 - January 1995)
Thomas Taapken Education
Technische Universität Berlin
Doctor of Philosophy (Chemistry)
1990-1994
The University of Göttingen
(Chemistry)
1984-1990
Thomas Taapken Skills
Due Diligence
Life Sciences
Biotechnology Industry
Thomas Taapken Summary
Thomas Taapken, based in Bayern, Bayern, Germany, is currently a Member of the Board at Memo Therapeutics Ag. Thomas Taapken brings experience from previous roles at Memo Therapeutics Ag, Imcyse s.A. and Inflarx. Thomas Taapken holds a 1990 - 1994 Doctor of Philosophy in Chemistry @ Technische Universität Berlin. With a robust skill set that includes Due Diligence, Life Sciences, Biotechnology Industry and more. Thomas Taapken has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Thomas Taapken?
Find contact details for 700 million professionals.